BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 27586801)

  • 1. Update on calcium pyrophosphate deposition.
    Abhishek A; Doherty M
    Clin Exp Rheumatol; 2016; 34(4 Suppl 98):32-8. PubMed ID: 27586801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium pyrophosphate deposition disease: clinical manifestations.
    Ferrone C; Andracco R; Cimmino MA
    Reumatismo; 2012 Jan; 63(4):246-52. PubMed ID: 22303531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasound findings of calcium pyrophosphate deposition disease at metacarpophalangeal joints.
    Cipolletta E; Di Matteo A; Smerilli G; Di Carlo M; Di Battista J; Abhishek A; Grassi W; Filippucci E
    Rheumatology (Oxford); 2022 Oct; 61(10):3997-4005. PubMed ID: 35104308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal-induced arthritis after arthroplasty: 7 cases.
    Yahia SA; Zeller V; Desplaces N; Chazerain P; Lhotellier L; Marmor S; Ziza JM
    Joint Bone Spine; 2016 Oct; 83(5):559-62. PubMed ID: 27020953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conventional Radiology in Crystal Arthritis: Gout, Calcium Pyrophosphate Deposition, and Basic Calcium Phosphate Crystals.
    Jacques T; Michelin P; Badr S; Nasuto M; Lefebvre G; Larkman N; Cotten A
    Radiol Clin North Am; 2017 Sep; 55(5):967-984. PubMed ID: 28774457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local deposition of calcium pyrophosphate crystals in evolution of knee osteoarthritis.
    Reuge L; Van Linthoudt D; Gerster JC
    Clin Rheumatol; 2001; 20(6):428-31. PubMed ID: 11771528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology of articular chondrocalcinosis--role of ANKH.
    Abhishek A; Doherty M
    Nat Rev Rheumatol; 2011 Feb; 7(2):96-104. PubMed ID: 21102543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-Reported Outcomes in Calcium Pyrophosphate Deposition Disease Compared to Gout and Osteoarthritis.
    Whelan MG; Hayashi K; Altwies H; Tedeschi SK
    J Rheumatol; 2023 Aug; 50(8):1058-1062. PubMed ID: 37061233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium pyrophosphate deposition (CPPD) disease - Treatment options.
    Stack J; McCarthy G
    Best Pract Res Clin Rheumatol; 2021 Dec; 35(4):101720. PubMed ID: 34756508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in the therapeutic management of calcium pyrophosphate deposition disease.
    Voulgari PV; Venetsanopoulou AI; Drosos AA
    Front Med (Lausanne); 2024; 11():1327715. PubMed ID: 38529115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevalence of and factors related to calcium pyrophosphate dihydrate crystal deposition in the knee joint.
    Ryu K; Iriuchishima T; Oshida M; Kato Y; Saito A; Imada M; Aizawa S; Tokuhashi Y; Ryu J
    Osteoarthritis Cartilage; 2014 Jul; 22(7):975-9. PubMed ID: 24814686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of calcium pyrophosphate crystal deposition disease: A systematic review.
    Parperis K; Papachristodoulou E; Kakoullis L; Rosenthal AK
    Semin Arthritis Rheum; 2021 Feb; 51(1):84-94. PubMed ID: 33360232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Calcium pyrophosphate deposition disease].
    Richette P; Bardin T
    Presse Med; 2011 Sep; 40(9 Pt 1):856-64. PubMed ID: 21684108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arthropathies associated with calcium-containing crystals.
    McCarty DJ
    Hosp Pract (Off Ed); 1986 Oct; 21(10):109-15, 118-20. PubMed ID: 3020071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of joint motion on experimental calcium pyrophosphate dihydrate crystal induced arthritis.
    Fam AG; Schumacher HR; Clayburne G; Villanueva T; Baker D; Jimenez SA
    J Rheumatol; 1990 May; 17(5):644-55. PubMed ID: 2162961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Idiopathic calcium pyrophosphate dihydrate (CPPD) crystal deposition disease in a young male patient: a case report.
    Ahn JK; Kim HJ; Kim EH; Jeon CH; Cha HS; Ha CW; Ahn JM; Koh EM
    J Korean Med Sci; 2003 Dec; 18(6):917-20. PubMed ID: 14676457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium pyrophosphate deposition disease: a review of epidemiologic findings.
    Abhishek A
    Curr Opin Rheumatol; 2016 Mar; 28(2):133-9. PubMed ID: 26626724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasound imaging for the rheumatologist. XXV. Sonographic assessment of the knee in patients with gout and calcium pyrophosphate deposition disease.
    Filippucci E; Scirè CA; Delle Sedie A; Iagnocco A; Riente L; Meenagh G; Gutierrez M; Bombardieri S; Valesini G; Montecucco C; Grassi W
    Clin Exp Rheumatol; 2010; 28(1):2-5. PubMed ID: 20346230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diastolic dysfunction of ventricles in patients with calcium pyrophosphate crystal deposition disease while receiving anti-inflammatory therapy].
    Eliseev MS; Zheliabina OV; Kirillova IG; Korsakova YO
    Ter Arkh; 2023 Jul; 95(5):386-391. PubMed ID: 38158992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of calcium pyrophosphate crystal arthritis and basic calcium phosphate crystal arthropathy.
    Abhishek A; Doherty M
    Rheum Dis Clin North Am; 2014 May; 40(2):177-91. PubMed ID: 24703342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.